A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

Clinical trial NCT07612267 · RECRUITING

Trial details

NCT number: NCT07612267
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Lactation Inflammatory Bowel Disease

Start date: 2026-08-05
Primary completion: 2028-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.